572 related articles for article (PubMed ID: 16997897)
1. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and endometrial cancer risk: a meta-analysis.
Grady D; Gebretsadik T; Kerlikowske K; Ernster V; Petitti D
Obstet Gynecol; 1995 Feb; 85(2):304-13. PubMed ID: 7824251
[TBL] [Abstract][Full Text] [Related]
3. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease.
Weiss JM; Saltzman BS; Doherty JA; Voigt LF; Chen C; Beresford SA; Hill DA; Weiss NS
Am J Epidemiol; 2006 Jul; 164(1):56-62. PubMed ID: 16675538
[TBL] [Abstract][Full Text] [Related]
5. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
6. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
[TBL] [Abstract][Full Text] [Related]
7. Menopausal hormone use and endometrial cancer, by tumor grade and invasion.
Shapiro JA; Weiss NS; Beresford SA; Voigt LF
Epidemiology; 1998 Jan; 9(1):99-101. PubMed ID: 9430277
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
11. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormones and risk of ovarian cancer.
Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
[TBL] [Abstract][Full Text] [Related]
13. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy use and variations in the risk of breast cancer.
Opatrny L; Dell'Aniello S; Assouline S; Suissa S
BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
Nozaki M; Koera K; Nagata H; Nakano H
J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
[TBL] [Abstract][Full Text] [Related]
16. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
17. Balancing safety and efficacy focus on endometrial protection.
Boroditsky RS
J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
[TBL] [Abstract][Full Text] [Related]
18. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
Comerci JT; Fields AL; Runowicz CD; Goldberg GL
Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
20. Does HRT modify risk of gynecological cancers?
Schneider HP; Birkhauser M
Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
